Attributable Risk of H. pylori in Peptic Ulcer Disease

被引:4
作者
Toshiro Sugiyama
Keiko Nishikawa
Yoshito Komatsu
Jyun Ishizuka
Takuji Mizushima
Ayae Kumagai
Mototsugu Kato
Nagahito Saito
Hiroshi Takeda
Masahiro Asaka
James W. Freston
机构
[1] Hokkaido University School of Medicine,Third Department of Internal Medicine
[2] University of Connecticut School of Medicine,Department of Medicine
关键词
H. pylori; NSAIDs; peptic ulcer; attributable risk;
D O I
10.1023/A:1005600831851
中图分类号
学科分类号
摘要
Recent reports in the United States have found that fewer peptic ulcers are due to Helicobacter pylori than previously believed. The aim of this study is to determine if the declining prevalence of H. pylori infection in the general population can account for the apparent increase in the frequency of non-H. pylori ulcers. A total of 396 patients with peptic ulcer or ulcer scar were enrolled in this study. The pre-1950 population consisted of 149 patients with gastric ulcers and with 44 duodenal ulcers. The post-1950 population consisted of 96 patients with gastric ulcers and 107 with duodenal ulcers. The frequency of H. pylori-negative gastric ulcers was 5.4% in patients born before 1950 and 4.2% in patients born after 1950, and the frequency of H. pylori-negative duodenal ulcers was 0% and 1.9%, respectively. There are no statistical differences between the two populations in gastric and duodenal ulcers. H. pylori seropositivity was 74.9% in asymptomatic volunteers born before 1950 and 20.7% in those born after 1950 (P < 0.01) in the general population. The attributable risk of H. pylori infection in peptic ulcer diseases was not affected by the prevalence of H. pylori infection in the general population in Japan. This suggests that the apparent increase in frequency of non-H. pylori ulcers in the United States is not simply due to the declining prevalence of infection. Other explanations for non-H. pylori ulcers should be sought.
引用
收藏
页码:307 / 310
页数:3
相关论文
共 64 条
[1]
Hopkins RJ(1996)Relationship between Gastroenterology 110 1244-1252
[2]
Girardi LS(1994) eradication and reduced duodenal and gastric ulcer recurrence: A review Am J Gastroenterol 89 116-128
[3]
Turney EA(1997)Helicobacter pylori. Lancet 350 975-979
[4]
Marshall BJ(1998)Randomized trial of eradication of Lancet 352 1016-1021
[5]
Chan FKL(1996) before non-steroidal antiinflammatory drug therapy to prevent peptic ulcers Am J Gastroenterol 91 1926-578
[6]
Sung JY(1998)Randomized controlled trial of Am J Gastroenterol 93 574-17
[7]
Chung SCS(1997) eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study J Clin Gastroenterol 24 2-831
[8]
Yung TMY(1996)The prevalence of J Gastroenterol Hepatol 11 825-766
[9]
Leung VKS(1992) in duodenal ulcer diseases: A community based study Gastroenterology 102 760-155
[10]
Lee YT(1995)Prevalence of J Gastroenterol 30 149-1008